AMSTERDAM, Aug. 5, 2015 /PRNewswire/ -- Constellium N.V. (NYSE and Euronext: CSTM) today reported results for the second quarter ended June 30, 2015. Highlights below are in comparison to the second quarter of 2014.
Logo - http://photos.prnewswire.com/prnh/20130624/NY37453LOGO
- Shipments of 386 thousand metric tons, up 38%
- Revenue of €1.375 billion, up 49%
- Adjusted EBITDA of €93 million, including €19 million from Muscle Shoals adjusted for Midwest premium impact
- Strong Adjusted Free Cash Flow of €72 million and liquidity of €690 million
- Automotive rolled shipments up 18%; Automotive extruded shipments up 16%
- Muscle Shoals operational integration progressing well, still working through metal management issues
- Q2 2015 Diluted EPS of (€0.45), EPS excluding unrealized gains on derivatives of (€0.61)
Constellium's second quarter 2015 results include a record Adjusted EBITDA in our AS&I segment and better than anticipated results in our A&T business. We also achieved record shipments and Adjusted EBITDA in P&ARP due to the acquisition of Wise Metals in January 2015.
Revenues for the second quarter 2015 were €1.375 billion, an increase of 49% from the second quarter 2014, of which €308 million were contributed by Muscle Shoals. Adjusted EBITDA was €93 million, including €19 million from Muscle Shoals. This is an increase of 15% from the second quarter 2014 Adjusted EBITDA of €81 million. For the six months ended June 30, 2015, Constellium reported Adjusted EBITDA of €188 million, including €44 million from Muscle Shoals compared to €152 million for the same period in 2014. Second quarter 2015 shipments were 386k metric tons, an increase of 38% from second quarter 2014, of which 111k metric tons were contributed by Muscle Shoals. Adjusted EBITDA per metric ton for the second quarter 2015 was €241 compared to €291 for the second quarter 2014.
Commenting on the second quarter 2015 results, Pierre Vareille, Constellium's Chief Executive Officer said: "Second quarter results reflect the overall strength of our segments and our historical business is doing well. However, P&ARP faces some headwinds in the U.S., which we expect to overcome by year-end. The operational integration of Muscle Shoals is progressing well and our Body-in-White initiative is advancing in line with our long-term strategy. We continue to see strong demand in our targeted markets."
Update on Wise Metals Acquisition
The operational integration of the Muscle Shoals facility, acquired from Wise Metals, is progressing well. We are generating cash faster than expected as we are ahead of schedule in reducing our working capital at Muscle Shoals, which made a significant contribution to the €72 million adjusted free cash flow in this quarter. Notably, the improvement in adjusted free cash flow in the second quarter 2015 reflects a 20% reduction in inventory at Muscle Shoals compared to the last quarter.
In the first half of 2015, the performance of Muscle Shoals reflected the unprecedented downward movement in the U.S. Midwest aluminium premiums, which fell from $524 per metric ton as of January 5, 2015 to $185 per metric ton as of June 30, 2015. The contracts in place at Muscle Shoals have more limited premium pass-through than is customary in most of Constellium's contracts and, as a result, the drop in premiums resulted in a negative impact of €19 million in the second quarter 2015 and €20 million for the first half of 2015. After adjusting for this negative impact, Adjusted EBITDA for the second quarter and six months ended June 30, 2015 for Muscle Shoals were €19 million and €44 million, respectively. As part of our integration, we have been actively engaged with our customers and suppliers to bring the Muscle Shoals contracts in line with our standards. We are making good progress in addressing metal management practices with our customers and suppliers to resolve these issues.
We currently expect the financial performance of the second half of 2015 for Muscle Shoals to be lower than the performance in the first half as we continue to address metal management issues. These issues are expected to extend until the end of the year, particularly those related to annual procurement contracts. In addition, although volumes are on track, they are expected to be lower in the second half due to normal seasonality with less favorable product mix. The first half of 2015 also benefited from a competitor outage. Consequently, we currently expect the 2015 full year Adjusted EBITDA for Muscle Shoals to be in the range of €60 million to €75 million, at constant currency.
We expect to get through these negative headwinds by the end of 2015 and most of the production of the plant is already contracted for in 2016. As a result, Muscle Shoals is expected to be fully integrated by the end of 2015 and we are expecting our P&ARP segment Adjusted EBITDA to substantially improve in 2016, as we continue to implement our long-term strategy.
Quarter Highlights and Recent Developments
In April 2015, Constellium unveiled its newly expanded plant in Van Buren, Michigan as part of its strategic progress to take full advantage of the growing automotive demand for aluminium structures in North America. The 210,000 square foot expansion project has doubled the plant manufacturing capacity for a total investment of $40 million.
Our investments in Body-in-White (BiW) finishing projects are proceeding according to plan in both Europe and in the U.S. Our 100k metric ton expansions at both Neuf-Brisach and Bowling Green, Kentucky (our joint venture with UACJ) are expected to commence ramp up by mid-2016, as previously announced.
In April 2015, we announced our decision to build a second BiW finishing line in the U.S. to further support the growing demand for aluminium rolled products from the U.S. automotive industry. The investment is part of the previously announced $750 million strategic plan to increase BiW production capacity by 200k metric tons, which is progressing as planned.
The prospects for the development of BiW remain strong in Europe and in the U.S. and support market projections, which reinforces our confidence in the strategy we have developed.
In June 2015, Constellium appointed Ingrid Joerg as President of our Aerospace and Transportation business unit. Ms. Joerg, who previously served as Chief Executive Officer of Aleris Rolled Products Europe, brings extensive aluminium industry experience to the Company.
Group Summary |
||||||
Q2 |
Q2 |
Var. |
Half-Year |
Half-Year 2014 |
Var. |
|
Shipments (k metric tons) |
386 |
279 |
38% |
767 |
548 |
40% |
Revenues (€ millions) |
1,375 |
920 |
49% |
2,768 |
1,803 |
53% |
Adjusted EBITDA (€ millions) |
93 |
81 |
15% |
188 |
152 |
24% |
Adjusted EBITDA per metric ton (€) |
241 |
291 |
(17%) |
245 |
277 |
(12%) |
Adjusted EBITDA per metric ton and percentage changes are calculated on unrounded underlying figures.
The difference between the sum of reported segment Adjusted EBITDA and the Group Adjusted EBITDA is related to Holdings and Corporate (see page 14).
Results by Segment |
||||||
Packaging & Automotive Rolled Products (P&ARP) |
||||||
Q2 |
Q2 |
Var. |
Half-Year |
Half-Year 2014 |
Var. |
|
Shipments (k metric tons) |
268 |
165 |
62% |
534 |
320 |
67% |
Revenues (€ millions) |
733 |
400 |
83% |
1,507 |
760 |
98% |
Adjusted EBITDA (€ millions) |
53 |
36 |
49% |
106 |
63 |
70% |
Adjusted EBITDA per metric ton (€) |
201 |
219 |
(8%) |
199 |
195 |
2% |
Adjusted EBITDA per metric ton and percentage changes are calculated on unrounded underlying figures.
The consolidation of the Muscle Shoals facility resulted in a positive impact to the P&ARP segment with a 62% growth in shipments to 268k metric tons, and an Adjusted EBITDA of €53 million. Adjusted EBITDA per metric ton of €201 for P&ARP decreased by 8% over the same period in the prior year. The increase in shipments and revenue in the second quarter of 2015 primarily reflects both the newly acquired Muscle Shoals facility and strong growth in automotive rolled products. The P&ARP segment Adjusted EBITDA for the second quarter 2015 was also impacted by a negative €4 million foreign exchange effect.
For the six months ended June 30 2015, Adjusted EBITDA was €106 million which represented a 70% increase from €63 million over the same period in 2014, and primarily reflects our acquisition of Wise Metals.
Aerospace & Transportation (A&T) |
||||||
Q2 |
Q2 |
Var. |
Half-Year |
Half-Year 2014 |
Var. |
|
Shipments (k metric tons) |
63 |
62 |
1% |
122 |
123 |
(1%) |
Revenues (€ millions) |
366 |
301 |
22% |
717 |
600 |
19% |
Adjusted EBITDA (€ millions) |
30 |
31 |
(4%) |
57 |
55 |
3% |
Adjusted EBITDA per metric ton (€) |
470 |
497 |
(5%) |
465 |
447 |
4% |
Adjusted EBITDA per metric ton and percentage changes are calculated on unrounded underlying figures.
Second quarter 2015 results in the A&T segment decreased slightly to €30 million of Adjusted EBITDA, a 4% decrease in comparison to the second quarter of 2014. Shipments were 63k metric tons and represent an increase of 1% from the same period last year. There was also a favorable product mix compared with the prior year with higher aerospace business and lower transportation, industry, and other rolled products. Second quarter 2015 A&T results benefited from a favorable foreign exchange effect of €6 million which was offset by higher costs, particularly in maintenance.
For the six months ended June 30 2015, Adjusted EBITDA was €57 million, an increase of 3% from the same period in 2014. Shipments remain stable and Adjusted EBITDA per ton was €465, a 4% increase from 2014. Despite slower growth in demand for AIRWARE®, the recovery plans for this segment continue to progress. Aerospace manufacturers continue to have a strong order book and we are moving to restore and enhance our aerospace capacity in our Issoire, France and Ravenswood, West Virginia plants.
Automotive Structures & Industry (AS&I) |
||||||
Q2 |
Q2 |
Var. |
Half-Year |
Half-Year 2014 |
Var. |
|
Shipments (k metric tons) |
57 |
53 |
7% |
113 |
106 |
6% |
Revenues (€ millions) |
281 |
227 |
24% |
552 |
455 |
21% |
Adjusted EBITDA (€ millions) |
22 |
20 |
9% |
40 |
39 |
1% |
Adjusted EBITDA per metric ton (€) |
382 |
373 |
2% |
351 |
370 |
(5%) |
Adjusted EBITDA per metric ton and percentage changes are calculated on unrounded underlying figures.
The AS&I segment achieved a record Adjusted EBITDA of €22 million in the second quarter of 2015, representing an increase of 9% from the second quarter 2014. This improvement was driven by higher volumes, 7% up at 57k metric tons, and a favorable mix with higher sales within our automotive structures business. Revenues increased by 24% to €281 million while EBITDA per ton increased by 2% to €382 from the comparable period in 2014.
For the six months ended June 30, 2015, the Adjusted EBITDA is marginally ahead of the comparable period in the prior year at €40 million. Higher volumes, which increased 6% to 113k metric tons, and a slightly more favorable product mix were partially offset by the effect of higher billet premiums of €3 million compared to the prior year.
Net income
Net income in the second quarter 2015 was a net loss of €47 million compared with a net income of €28 million in the second quarter of 2014. The decrease of €75 million is primarily attributable to a €24 million increase in depreciation charges, mainly due to Muscle Shoals, and asset impairment charges of €16 million related to our Swiss operations, a €19 million impact related to unrecovered Midwest premiums at Muscle Shoals, a €9 million increase in finance costs, and a €7 million charge for metal lag in the current quarter compared to a €2 million positive impact in the second quarter of 2014. In addition, there were unrealized gains on derivatives of €19 million in the second quarter 2015 compared with gains of €7 million in the same period in the prior year. The gains or losses arising from derivative instruments relating to trading transactions are recorded in segment Adjusted EBITDA only when realized.
For the six months ended June 30, 2015, we reported a net loss of €78 million compared with a net income of €58 million in the same period in 2014. Depreciation and impairment charges and finance costs were €63 million and €43 million higher, respectively, reflecting the acquisition of Muscle Shoals. Unrecovered Midwest premium charges amounted to €20 million and an unrealized loss of €27 million on derivatives was reported when compared to a €6 million gain in the same period in 2014.
Earnings per share
For the second quarter 2015, the fully diluted earnings per share was a negative €0.45 versus a positive €0.26 for the second quarter 2014. For the six months ended June 30, 2015, the fully diluted earnings per share was a negative €0.75 versus a positive €0.53 per share for the same period in 2014. Excluding the impact of unrealized gains and losses on derivative instruments, our earnings per share would have been a negative €0.61 and a positive €0.22 for the second quarter of 2015 and 2014, respectively, and a negative €0.52 and a positive €0.50 for the six months ending June 30, 2015 and 2014, respectively. The change in earnings per share mainly reflects the higher depreciation, finance costs, and other factors described under "Net income".
Liquidity and cash flow
Our liquidity position remains strong. As of June 30, 2015, liquidity was €690 million, comprised of €182 million available under our factoring facilities, €129 million available under our asset based lending facilities, €10 million available under our revolving credit facilities, and €369 million of cash and cash equivalents.
Adjusted free cash flow was a positive €72 million for the second quarter of 2015 versus a positive €13 million for the second quarter of 2014. This reflects higher net cash flows from operating activities this quarter compared with the second quarter 2014, mainly due to a large reduction in working capital from March 2015, compared with an increase in working capital over the same quarter in 2014. This improvement in the second quarter of 2015 includes a 20% inventory reduction at Muscle Shoals. These higher cash flows from operating activities were partially offset by an increase of capital expenditures from €37 million to €79 million for the second quarter of 2015 as a result of our current growth initiatives.
For the six months ended June 30, 2015, adjusted free cash flow was zero compared with a deficit of €35 million in the corresponding period in 2014. In the first half of 2015, the cash flow from operations of €163 million, excluding margin calls, was offset by capital expenditures of €163 million.
Net debt at June 30, 2015 decreased to €1.7 billion compared with €1.8 billion as of March 31, 2015 and our cash and cash equivalents totaled €369 million compared to our cash balance of €352 million at the end of the first quarter 2015. Our net debt at December 31, 2014, prior to the acquisition of Wise Metals, was €224 million and our cash and cash equivalent was €989 million.
Forward-looking statements
Certain statements contained in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. This press release may contain "forward looking statements" with respect to our business, results of operations and financial condition, and our expectations or beliefs concerning future events and conditions. You can identify forward-looking statements because they contain words such as, but not limited to, "believes," "expects," "may," "should," "approximately," "anticipates," "estimates," "intends," "plans," "targets," likely," "will," "would," "could" and similar expressions (or the negative of these terminologies or expressions). All forward-looking statements involve risks and uncertainties. Many risks and uncertainties are inherent in our industry and markets. Others are more specific to our business and operations. These risks and uncertainties include, but are not limited to, the ability of Constellium and Wise to achieve expected synergies and the timing thereof; the risk that the businesses will not be integrated successfully or such integration may be more difficult, time-consuming or costly than expected; Constellium's increased levels of indebtedness as a result of the acquisition of Wise Metals, which could limit Constellium's operating flexibility and opportunities; the potential failure to retain key employees as a result of the acquisition of Wise Metals or during the integration of the business, the loss of customers, suppliers and other business relationships as a result of the acquisition of Wise Metals; disruptions to business operations resulting from the acquisition of Wise Metals; slower or lower than expected growth in the North American market for Body-in-White aluminium rolled products and other risk factors set forth under the heading "Risk Factors" in our Annual Report on Form 20-F, and as described from time to time in subsequent reports filed with the U.S. Securities and Exchange Commission. The occurrence of the events described and the achievement of the expected results depend on many events, some or all of which are not predictable or within our control. Consequently, actual results may differ materially from the forward-looking statements contained in this press release. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as required by law.
About Constellium
Constellium (NYSE and Euronext: CSTM) is a global sector leader that develops innovative, value added aluminium products for a broad scope of markets and applications, including aerospace, automotive and packaging. Constellium generated €3.7 billion of revenue in 2014. Constellium's earnings materials for the quarter ended June 30, 2015 are also available on the company's website (www.constellium.com).
UNAUDITED INTERIM CONSOLIDATED INCOME STATEMENT |
|||||||||||||
(in millions of Euros) |
Three months |
Three months |
Six months ended |
Six months ended |
|||||||||
Revenue |
1,375 |
920 |
2,768 |
1,803 |
|||||||||
Cost of sales |
(1,283) |
(790) |
(2,535) |
(1,556) |
|||||||||
Gross profit |
92 |
130 |
233 |
247 |
|||||||||
Selling and administrative expenses |
(62) |
(49) |
(127) |
(101) |
|||||||||
Research and development expenses |
(9) |
(8) |
(20) |
(17) |
|||||||||
Restructuring costs |
(5) |
(2) |
(5) |
(5) |
|||||||||
Other (losses) / gains - net |
(19) |
(1) |
(88) |
2 |
|||||||||
Income from operations |
(3) |
70 |
(7) |
126 |
|||||||||
Other expenses |
- |
- |
- |
(1) |
|||||||||
Finance income |
23 |
- |
77 |
- |
|||||||||
Finance costs |
(59) |
(27) |
(156) |
(36) |
|||||||||
Finance costs - net |
(36) |
(27) |
(79) |
(36) |
|||||||||
Share of loss of joint-ventures |
- |
- |
(1) |
- |
|||||||||
(Loss) / income before income tax |
(39) |
43 |
(87) |
89 |
|||||||||
Income tax (expense) / benefit |
(8) |
(15) |
9 |
(31) |
|||||||||
Net (loss) / income |
(47) |
28 |
(78) |
58 |
|||||||||
Net (loss) / income attributable to: |
|||||||||||||
Owners of the Company |
(47) |
28 |
(79) |
57 |
|||||||||
Non-controlling interests |
- |
- |
1 |
1 |
|||||||||
Net (loss) / income |
(47) |
28 |
(78) |
58 |
|||||||||
EARNINGS PER SHARE ATTRIBUTABLE TO THE EQUITY HOLDERS OF THE COMPANY |
|||||||||||||
(in Euros per share) |
Three months ended |
Three months ended |
Six months ended |
Six months ended |
|||||||||
Basic |
(0.45) |
0.26 |
(0.75) |
0.54 |
|||||||||
Diluted |
(0.45) |
0.26 |
(0.75) |
0.53 |
|||||||||
UNAUDITED INTERIM CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME / (LOSS) |
|||||||||
(in millions of Euros) |
Three months |
Three months |
Six months ended |
Six months ended |
|||||
Net (loss) / income |
(47) |
28 |
(78) |
58 |
|||||
Other comprehensive income / (loss) |
|||||||||
Items that will not be reclassified |
|||||||||
Remeasurement on post-employment |
75 |
(17) |
16 |
(43) |
|||||
Deferred tax on remeasurement on |
(17) |
3 |
(6) |
7 |
|||||
Cash flow hedges |
- |
- |
(9) |
- |
|||||
Deferred tax on cash flow hedges |
- |
- |
3 |
- |
|||||
Items that may be reclassified |
|||||||||
Currency translation differences |
(11) |
- |
22 |
- |
|||||
Other comprehensive income / (loss) |
47 |
(14) |
26 |
(36) |
|||||
Total comprehensive income / (loss) |
- |
14 |
(52) |
22 |
|||||
Attributable to: |
|||||||||
Owners of the Company |
- |
14 |
(53) |
21 |
|||||
Non-controlling interests |
- |
- |
1 |
1 |
|||||
Total comprehensive income / (loss) |
- |
14 |
(52) |
22 |
|||||
UNAUDITED INTERIM CONSOLIDATED STATEMENT OF FINANCIAL POSITION |
|||||||||
(in millions of Euros) |
At June |
At December |
|||||||
Assets |
|||||||||
Non-current assets |
|||||||||
Goodwill |
362 |
11 |
|||||||
Intangible assets |
155 |
17 |
|||||||
Property, plant and equipment |
1,437 |
632 |
|||||||
Investment in joint ventures |
31 |
21 |
|||||||
Deferred income tax assets |
235 |
190 |
|||||||
Trade receivables and other |
48 |
48 |
|||||||
Other financial assets |
39 |
33 |
|||||||
2,307 |
952 |
||||||||
Current assets |
|||||||||
Inventories |
622 |
432 |
|||||||
Trade receivables and other |
743 |
568 |
|||||||
Other financial assets |
99 |
57 |
|||||||
Cash and cash equivalents |
369 |
989 |
|||||||
1,833 |
2,046 |
||||||||
Assets classified as held for sale |
14 |
14 |
|||||||
Total assets |
4,154 |
3,012 |
|||||||
Equity |
|||||||||
Share capital |
2 |
2 |
|||||||
Share premium |
162 |
162 |
|||||||
Retained deficit and other reserves |
(258) |
(207) |
|||||||
Equity attributable to owners of the Company |
(94) |
(43) |
|||||||
Non-controlling interests |
7 |
6 |
|||||||
(87) |
(37) |
||||||||
Liabilities |
|||||||||
Non-current liabilities |
|||||||||
Borrowings |
2,012 |
1,205 |
|||||||
Trade payables and other |
46 |
31 |
|||||||
Pension and other post-employment benefit |
668 |
654 |
|||||||
Other financial liabilities |
42 |
40 |
|||||||
Provisions |
122 |
61 |
|||||||
2,890 |
1,991 |
||||||||
Current liabilities |
|||||||||
Borrowings |
166 |
47 |
|||||||
Trade payables and other |
1,028 |
872 |
|||||||
Income taxes payable |
5 |
11 |
|||||||
Other financial liabilities |
94 |
71 |
|||||||
Provisions |
44 |
49 |
|||||||
1,337 |
1,050 |
||||||||
Liabilities classified as held for sale |
14 |
8 |
|||||||
Total liabilities |
4,241 |
3,049 |
|||||||
Total equity and liabilities |
4,154 |
3,012 |
|||||||
UNAUDITED INTERIM CONSOLIDATED STATEMENT OF CHANGES IN EQUITY |
|||||||||||||||||||||||||
(in millions of Euros) |
Share |
Share |
Remeasure- |
Cash flow |
Foreign |
Other |
Retained |
Total |
Non- |
Total |
|||||||||||||||
As at January 1, 2015 |
2 |
162 |
(146) |
6 |
(28) |
6 |
(45) |
(43) |
6 |
(37) |
|||||||||||||||
Net loss |
- |
- |
- |
- |
- |
- |
(79) |
(79) |
1 |
(78) |
|||||||||||||||
Other comprehensive |
- |
- |
10 |
(6) |
22 |
- |
- |
26 |
- |
26 |
|||||||||||||||
Total comprehensive |
- |
- |
10 |
(6) |
22 |
- |
(79) |
(53) |
1 |
(52) |
|||||||||||||||
Transactions with the |
|||||||||||||||||||||||||
Share equity plan |
- |
- |
- |
- |
- |
2 |
- |
2 |
- |
2 |
|||||||||||||||
As at June 30, 2015 |
2 |
162 |
(136) |
- |
(6) |
8 |
(124) |
(94) |
7 |
(87) |
|||||||||||||||
(in millions of Euros) |
Share |
Share |
Remeasure- |
Foreign |
Other |
Retained |
Total |
Non- |
Total |
||||||||||||||||
As at January 1, 2014 |
2 |
162 |
(23) |
(14) |
1 |
(96) |
32 |
4 |
36 |
||||||||||||||||
Net income |
- |
- |
- |
- |
- |
57 |
57 |
1 |
58 |
||||||||||||||||
Other comprehensive loss |
- |
- |
(36) |
- |
- |
- |
(36) |
- |
(36) |
||||||||||||||||
Total comprehensive |
- |
- |
(36) |
- |
- |
57 |
21 |
1 |
22 |
||||||||||||||||
Transactions with the |
|||||||||||||||||||||||||
Share equity plan |
- |
- |
- |
- |
2 |
- |
2 |
- |
2 |
||||||||||||||||
As at June 30, 2014 |
2 |
162 |
(59) |
(14) |
3 |
(39) |
55 |
5 |
60 |
||||||||||||||||
(in millions of Euros) |
Share |
Share |
Remeasure- |
Cash flow |
Foreign |
Other |
Retained |
Total |
Non- |
Total |
|||||||||||||||
As at January 1, 2014 |
2 |
162 |
(23) |
- |
(14) |
1 |
(96) |
32 |
4 |
36 |
|||||||||||||||
Net income |
- |
- |
- |
- |
- |
- |
51 |
51 |
3 |
54 |
|||||||||||||||
Other comprehensive loss |
- |
- |
(123) |
6 |
(14) |
- |
- |
(131) |
1 |
(130) |
|||||||||||||||
Total comprehensive |
- |
- |
(123) |
6 |
(14) |
- |
51 |
(80) |
4 |
(76) |
|||||||||||||||
Transactions with the |
|||||||||||||||||||||||||
Share equity plan |
- |
- |
- |
- |
- |
4 |
- |
4 |
- |
4 |
|||||||||||||||
MEP shares changes |
- |
- |
- |
- |
- |
1 |
- |
1 |
- |
1 |
|||||||||||||||
Transactions with non- |
- |
- |
- |
- |
- |
- |
- |
- |
(2) |
(2) |
|||||||||||||||
As at December 31, 2014 |
2 |
162 |
(146) |
6 |
(28) |
6 |
(45) |
(43) |
6 |
(37) |
|||||||||||||||
UNAUDITED INTERIM CONSOLIDATED STATEMENT OF CASH FLOWS |
|||||||||||||||||||||||||
(in millions of Euros) |
Three months |
Three months |
Six months |
Six months |
|||||||||||||||||||||
Cash flows from / (used in) operating activities |
|||||||||||||||||||||||||
Net (loss) / income |
(47) |
28 |
(78) |
58 |
|||||||||||||||||||||
Adjustments for: |
|||||||||||||||||||||||||
Income tax (benefit) / expense |
8 |
15 |
(9) |
31 |
|||||||||||||||||||||
Finance costs - net |
36 |
27 |
79 |
36 |
|||||||||||||||||||||
Depreciation and Impairment |
51 |
11 |
83 |
20 |
|||||||||||||||||||||
Restructuring costs and other provisions |
3 |
- |
1 |
2 |
|||||||||||||||||||||
Defined benefit pension costs |
12 |
9 |
25 |
10 |
|||||||||||||||||||||
Unrealized losses / (gains) on derivatives net and from |
(16) |
(9) |
30 |
(6) |
|||||||||||||||||||||
Losses on disposal and assets classified as held for sale |
10 |
6 |
10 |
6 |
|||||||||||||||||||||
Share of loss of joint ventures |
- |
- |
1 |
- |
|||||||||||||||||||||
Other |
1 |
- |
2 |
2 |
|||||||||||||||||||||
Changes in working capital: |
|||||||||||||||||||||||||
Inventories |
71 |
(20) |
63 |
(36) |
|||||||||||||||||||||
Trade receivables |
24 |
(32) |
(24) |
(125) |
|||||||||||||||||||||
Margin calls |
1 |
- |
1 |
11 |
|||||||||||||||||||||
Trade payables |
28 |
47 |
26 |
84 |
|||||||||||||||||||||
Other working capital |
(11) |
(18) |
- |
(14) |
|||||||||||||||||||||
Changes in other operating assets and liabilities: |
|||||||||||||||||||||||||
Provisions |
(3) |
(4) |
(6) |
(7) |
|||||||||||||||||||||
Income tax paid |
(5) |
1 |
(14) |
(3) |
|||||||||||||||||||||
Pension liabilities and other post-employment benefit |
(11) |
(11) |
(26) |
(23) |
|||||||||||||||||||||
Net cash flows from operating activities |
152 |
50 |
164 |
46 |
|||||||||||||||||||||
Cash flows (used in) / from investing activities |
|||||||||||||||||||||||||
Acquisitions of subsidiaries net of cash required |
- |
- |
(348) |
- |
|||||||||||||||||||||
Purchases of property, plant and equipment |
(79) |
(37) |
(163) |
(70) |
|||||||||||||||||||||
Issuance of shares of joint-ventures |
- |
- |
(9) |
- |
|||||||||||||||||||||
Proceeds from finance lease |
2 |
2 |
3 |
3 |
|||||||||||||||||||||
Proceeds from disposal |
1 |
- |
- |
- |
|||||||||||||||||||||
Other investing activities |
- |
(5) |
- |
(5) |
|||||||||||||||||||||
Net cash flows used in investing activities |
(76) |
(40) |
(517) |
(72) |
|||||||||||||||||||||
Cash flows (used in) / from financing activities |
|||||||||||||||||||||||||
Interests paid |
(53) |
(9) |
(57) |
(16) |
|||||||||||||||||||||
Proceeds received from term loan and senior notes |
- |
587 |
- |
587 |
|||||||||||||||||||||
(Repayment) / proceeds of other loans |
(19) |
4 |
(218) |
3 |
|||||||||||||||||||||
Repayment of Term Loans |
- |
(330) |
- |
(331) |
|||||||||||||||||||||
Payment of deferred financing costs |
- |
(15) |
(1) |
(15) |
|||||||||||||||||||||
Other financing activities |
16 |
(23) |
6 |
(31) |
|||||||||||||||||||||
Net cash flows (used in) / from financing activities |
(56) |
214 |
(270) |
197 |
|||||||||||||||||||||
Net (decrease) / increase in cash and cash equivalents |
20 |
224 |
(623) |
171 |
|||||||||||||||||||||
Cash and cash equivalents - beginning of period |
354 |
179 |
991 |
233 |
|||||||||||||||||||||
Effect of exchange rate changes on cash and cash |
(1) |
1 |
5 |
- |
|||||||||||||||||||||
Cash and cash equivalents - end of period |
373 |
404 |
373 |
404 |
|||||||||||||||||||||
Less: Cash and cash equivalents classified as held for sale |
(4) |
(1) |
(4) |
(1) |
|||||||||||||||||||||
Cash and cash equivalents as reported in the Statement |
369 |
403 |
369 |
403 |
|||||||||||||||||||||
SEGMENT ADJUSTED EBITDA |
|||||||||
(in millions of Euros) |
Three months |
Three months |
Six months |
Six months |
|||||
A&T |
30 |
31 |
57 |
55 |
|||||
P&ARP |
53 |
36 |
106 |
63 |
|||||
AS&I |
22 |
20 |
40 |
39 |
|||||
Holdings and Corporate |
(12) |
(6) |
(15) |
(5) |
|||||
Total |
93 |
81 |
188 |
152 |
|||||
REVENUE AND SHIPMENTS BY PRODUCT LINE |
|||||||||
(in k metric tons) |
Six months ended June 30, 2015 |
Six months ended June 30, 2014 |
|||||||
Aerospace rolled products |
58 |
56 |
|||||||
Transportation, industry, and other rolled products |
64 |
67 |
|||||||
Packaging rolled products |
454 |
255 |
|||||||
Automotive rolled products |
44 |
37 |
|||||||
Specialty and other thin-rolled products |
36 |
28 |
|||||||
Automotive extruded products |
51 |
45 |
|||||||
Other extruded products |
62 |
61 |
|||||||
Other |
(2) |
(1) |
|||||||
Total shipments |
767 |
548 |
|||||||
(in millions of Euros) |
|||||||||
Aerospace rolled products |
391 |
341 |
|||||||
Transportation, industry, and other rolled products |
326 |
259 |
|||||||
Packaging rolled products |
1,222 |
554 |
|||||||
Automotive rolled products |
144 |
105 |
|||||||
Specialty and other thin-rolled products |
141 |
102 |
|||||||
Automotive extruded products |
260 |
198 |
|||||||
Other extruded products |
292 |
257 |
|||||||
Other |
(8) |
(13) |
|||||||
Total revenue |
2,768 |
1,803 |
|||||||
NON-GAAP MEASURES RECONCILIATIONS
Reconciliation of net income to Adjusted EBITDA (a non-GAAP measure) |
||||||||||||||
(in millions of Euros) |
Three months |
Three months |
Six months |
Six months |
||||||||||
Net (loss) / income |
(47) |
28 |
(78) |
58 |
||||||||||
Income tax expense / (benefits) |
8 |
15 |
(9) |
31 |
||||||||||
(Loss) / income before income tax |
(39) |
43 |
(87) |
89 |
||||||||||
Finance costs – net |
36 |
27 |
79 |
36 |
||||||||||
Other expenses |
- |
- |
- |
1 |
||||||||||
Share of loss of joint-ventures |
- |
- |
1 |
- |
||||||||||
Income from operations |
(3) |
70 |
(7) |
126 |
||||||||||
Depreciation and impairment |
51 |
11 |
83 |
20 |
||||||||||
Unrealized exchange losses / (gains) |
4 |
(2) |
3 |
- |
||||||||||
Unrealized (gains) / losses on derivatives |
(19) |
(7) |
27 |
(6) |
||||||||||
Losses on disposal and assets classified |
10 |
6 |
10 |
6 |
||||||||||
Restructuring costs |
5 |
2 |
5 |
5 |
||||||||||
Start-up and development costs |
5 |
2 |
9 |
5 |
||||||||||
Wise acquisition and integration costs |
3 |
- |
10 |
- |
||||||||||
Wise Midwest premium losses |
19 |
- |
20 |
- |
||||||||||
Unwinding of Wise previous hedging |
2 |
- |
4 |
- |
||||||||||
Effects of purchase accounting |
- |
- |
12 |
- |
||||||||||
Losses / (gains) on Ravenswood OPEB |
4 |
(1) |
4 |
(9) |
||||||||||
Metal price lag |
7 |
(2) |
- |
- |
||||||||||
Other |
5 |
2 |
8 |
5 |
||||||||||
Adjusted EBITDA |
93 |
81 |
188 |
152 |
||||||||||
Reconciliation of Diluted EPS from operations, excluding unrealized losses / gains on derivatives |
||||||||||||||
(in millions of Euros, except EPS in euros) |
Three |
Three |
Six months |
Six months |
||||||||||
Net (loss) / income attributable to owners of the |
(47) |
28 |
(79) |
57 |
||||||||||
Unrealized losses / (gains) on derivatives |
(19) |
(7) |
27 |
(6) |
||||||||||
Tax impact |
2 |
2 |
(3) |
2 |
||||||||||
Net (loss) / income excluding unrealized losses or |
(64) |
23 |
(55) |
53 |
||||||||||
Weighted average number of shares, fully diluted |
105,002,508 |
105,268,006 |
104,960,958 |
105,274,465 |
||||||||||
EPS fully diluted (in Euros) |
(0.45) |
0.26 |
(0.75) |
0.53 |
||||||||||
EPS fully diluted, excluding unrealized losses (in Euros) |
(0.61) |
0.22 |
(0.52) |
0.50 |
||||||||||
Reconciliation of net cash flow from operating activities to Adjusted free cash flow (a non-GAAP measure) |
||||||||||||||
Three |
Three |
Six months |
Six months |
|||||||||||
Net cash flow from operating activities |
152 |
50 |
164 |
46 |
||||||||||
Margin calls included in cash flow from operating |
(1) |
- |
(1) |
(11) |
||||||||||
Net cash flow from operating activities |
151 |
50 |
163 |
35 |
||||||||||
Capital expenditure |
(79) |
(37) |
(163) |
(70) |
||||||||||
Adjusted free cash flow |
72 |
13 |
0 |
(35) |
||||||||||
Reconciliation of borrowings to Net debt (a non-GAAP measure) |
||||||||||||||
(in millions of Euros) |
At June 30, |
At March 31, |
At December 31, |
|||||||||||
Borrowings |
2,178 |
2,277 |
1,252 |
|||||||||||
Fair value of cross |
(59) |
(97) |
(29) |
|||||||||||
Cash and cash |
(369) |
(352) |
(989) |
|||||||||||
Cash pledged for |
(12) |
(12) |
(10) |
|||||||||||
Net debt |
1,738 |
1,816 |
224 |
|||||||||||
Non-GAAP measures
In addition to the results reported in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board (all standards applied by the Group have been endorsed by the European Union), this press release includes information regarding certain financial measures which are not prepared in accordance with IFRS ("non-GAAP measures"). The non-GAAP financial measures used in this press release are: Adjusted EBITDA, Adjusted EBITDA per metric ton, Diluted Earnings Per Share (EPS) from continued and discontinued operations, excluding unrealized losses and gains on derivative instruments, Adjusted free cash flow and Net debt. Reconciliations to the most directly comparable IFRS financial measures are presented in the schedules to this press release. We believe these non-GAAP measures are important supplemental measures of our operating performance. By providing these measures, together with the reconciliations, we believe we are enhancing investors' understanding of our business and our results of operations, as well as assisting investors in evaluating how well we are executing our strategic initiatives. However, these non-GAAP financial measures supplement our IFRS disclosures and should not be considered an alternative to the IFRS measures and may not be comparable to similarly titled measures of other companies.
In considering the financial performance of the business, management and our chief operational decision maker, as defined by IFRS, analyze the primary financial performance measure of Adjusted EBITDA in all of our business segments. The most directly comparable IFRS measure to Adjusted EBITDA is our net income or loss for the period. We believe Adjusted EBITDA, as defined below, is useful to investors and is used by our management for measuring profitability because it excludes the impact of certain non-cash charges, such as depreciation, amortization, impairment and unrealized gains and losses on derivatives as well as items that do not impact the day-to-day operations and that management in many cases does not directly control or influence. Therefore, such adjustments eliminate items which have less bearing on our core operating performance.
Adjusted EBITDA measures are frequently used by securities analysts, investors and other interested parties in their evaluation of Constellium and in comparison to other companies, many of which present an Adjusted EBITDA-related performance measure when reporting their results.
Adjusted EBITDA is defined as profit from operations before depreciation, amortization and impairment, as adjusted to exclude losses on disposal of property, plant and equipment, acquisition and separation costs, restructuring costs, pension amendments and unrealized gains or losses on derivatives and foreign exchange differences on the remeasurement of monetary assets and liabilities, exceptional consulting costs, effects of purchase accounting inventory step-up adjustments, the effects of unwinding Wise's previous hedging policies, losses incurred at Wise as a result of unrecovered Midwest premiums, start-up and development costs, acquisition and integration costs incurred in connection with business combinations, share-based compensation expense and the effect of favorable or unfavorable metal price lag (the financial impact of the timing difference between when aluminium prices included within our revenues are established and when aluminium purchase prices included in our cost of sales are established).
Adjusted EBITDA is the measure of performance used by management in evaluating our operating performance, in preparing internal forecasts and budgets necessary for managing our business and, specifically in relation to the exclusion of the effect of favorable or unfavorable metal price lag, this measure allows management and the investor to assess operating results and trends without the impact of our accounting for inventories. We use the weighted average cost method in accordance with IFRS which leads to the purchase price paid for metal impacting our cost of goods sold and therefore profitability in the period subsequent to when the related sales price impacts our revenues. Management believes this measure also provides additional information used by our lending facilities providers with respect to the ongoing performance of our underlying business activities. Historically, we have used Adjusted EBITDA in calculating our compliance with the financial covenants under certain of our loan facilities.
Adjusted EBITDA is not a presentation made in accordance with IFRS, is not a measure of financial condition, liquidity or profitability and should not be considered as an alternative to profit or loss for the period, revenues or operating cash flows determined in accordance with IFRS.
Diluted earnings per share (EPS) from continued and discontinued operations excluding unrealized losses and gains on derivative instruments, excludes unrealized losses and gains on derivatives and the relevant tax impact from net income and is divided by the weighted average number of shares outstanding.
Adjusted free cash flow is net cash flow from operating activities, after capital expenditure and excluding margin calls. Net debt is defined as borrowings plus or minus the fair value of cross currency interest swaps less cash and cash equivalents and cash pledged for the issuance of guarantees.
Management believes that Adjusted free cash flow is a useful measure of the net cash flow generated or used by the business as it takes into account both the cash generated or consumed by operating activities, including working capital, and the capital expenditure requirements of the business. Management believes that Net debt is a useful measure of indebtedness because it takes into account the cash and cash equivalent balances held by the Company as well as the total external debt of the Company. Management believes that EPS from operations excluding unrealized losses or gains on derivatives is useful to investors because it provides additional information that facilitates understanding the impact of unrealized gains or losses on derivatives on our results.
Diluted EPS, Net debt and Adjusted free cash flow are not presentations made in accordance with IFRS, and should not be considered as an alternative to EPS, borrowings or operating cash flows determined in accordance with IFRS.
Share this article